The intraoperative neuromonitoring market was valued at US$ 2.71 billion in 2021 and is expected to reach US$ 5.64 billion by 2031. The market is expected to register a CAGR of 7.60% in 2023–2031. Technological advancement will likely remain key intraoperative neuromonitoring market trends.
Intraoperative neuromonitoring (IONM) drivers are the healthcare providers in charge of performing and interpreting neuromonitoring during surgical procedures. These individuals are usually highly trained neurophysiologists or technicians who use various monitoring techniques to assess the nervous system's functional integrity in real-time. Continuous technological development was improving the capabilities of IONM systems, allowing for more accurate and real-time monitoring during surgical procedures. The use of IONM was growing as surgeons and other medical professionals. In addition to improving patient safety, IONM reduces the risk of nerve damage by aiding in real-time nervous system monitoring during surgeries. To improve outcomes and reduce postoperative issues, surgeons use IONM to identify and treat potential surgical complications, such as nerve compression or damage. The need for IONM services to enhance patient safety during complicated procedures is growing as more surgeries are carried out. More surgeries lead to greater use of IONM, especially those involving delicate neural structures. To summarize, the increase in medical procedures impacts interoperative neuromonitoring, driving progress, growing the labor force, and highlighting the significance of integrating neuromonitoring into routine surgical procedures.
IONM, one of the fastest-growing subfields in neurology, uses electrophysiological technology to identify nervous structures that require protection during neurosurgical procedures and to see what is happening throughout the body. In general, recordings of electrical potentials flowing through the nervous system during surgery are used to monitor and map electrical signals in the body through neurologist-led IONM. IONM uses various techniques, each selected for highly particular uses. Moreover, several modalities may be used in the same surgery, depending on the selected procedure. Electroencephalography (EEG), somatosensory evoked potentials (SSEPs), visual evoked potentials (VEPs), brainstem auditory evoked potentials (BAEPs), motor evoked potentials (MEPs), electromyography, and other techniques may be used. Patients undergoing a wide range of central nervous system surgeries, such as interventional radiologic procedures, orthopedic spinal correction, epilepsy surgery, and craniofacial neurosurgery, can benefit from these techniques. Although it can be applied to other fields like vascular and endocrine surgery, it is most frequently used with spinal, epilepsy, brain tumors, and cerebrovascular surgery.
Ion Mapping and Microsurgery (IONM) enhances patient safety by helping surgeons avoid damage to critical brain structures and reduce the risk of complications during procedures by providing them with real-time feedback. During procedures, especially those involving proximity to vital nerves, surgeons can achieve precise navigation by employing IONM to monitor the functional integrity of the nervous system. IONM helps in the early detection of potential issues by lowering the risk of complications like nerve damage, paralysis, or sensory loss both during and after surgery. The combination of these factors underscores the importance of intraoperative neuromonitoring in modern surgical settings, advancing its adoption as standard practice in many procedures.
Due to rising global demand from a sizable population, the healthcare sector is constantly expanding, increasing new product development, launches, and approvals. Major market players also invest in research and development to promise innovation and create effective products. For instance, in October 2023, a revolutionary feature of the Neuromaster G1 intraoperative neuromonitoring (IONM) system is the One View solution, introduced by Nihon Kohden, a leading global manufacturer of medical electronic equipment. This novel approach enables the IONM software to seamlessly integrate neurological data with the patient's vital signs, such as heart rate, SpO2, temperature, and more, while maintaining the patient's anesthesia.
Key segments contributing to the intraoperative neuromonitoring market analysis derivation are product, source, application, modality, and end user.
The intraoperative neuromonitoring market report's geographic scope is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.
North America has dominated the intraoperative neuromonitoring market. In North America, the U.S. is the largest market for intraoperative neuromonitoring in 2023. Moreover, Asia Pacific is anticipated to grow with the highest CAGR in the coming years. IONM was becoming increasingly popular in Asia-Pacific due to rising awareness, advancements in technology, and an increase in surgical procedures. The growing demand for cutting-edge healthcare solutions and an understanding of the advantages of neuromonitoring during surgical procedures drive the growth of the Asia-Pacific IONM market. Major hospitals and healthcare facilities in the Asia-Pacific area have adopted IONM as a standard procedure for complex surgeries to improve patient safety. IONM is widely used in orthopedic and spine surgeries in the Asia-Pacific region, where there is a significant need to monitor neural structures during these procedures.
The regional trends and factors influencing the Intraoperative Neuromonitoring Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Intraoperative Neuromonitoring Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 2.71 Billion |
| Market Size by 2031 | US$ 5.64 Billion |
| Global CAGR (2023 - 2031) | 7.60% |
| Historical Data | 2021-2022 |
| Forecast period | 2023-2031 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Intraoperative Neuromonitoring Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Intraoperative Neuromonitoring Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The intraoperative neuromonitoring market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for Intraoperative Neuromonitoring and strategies:
The “Intraoperative Neuromonitoring Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas: